L04 · Antineoplastic and immunomodulating agents
Vynpenta (previously AvacopanChemoCentryx)
Indications
Induction of response in adult patients with granulomatosis with polyangiitis (Wegener’s) (GPA) or microscopic polyangiitis (MPA)
Composition
- Active substance
- avacopan
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Vynpenta (previously AvacopanChemoCentryx)
- Active substance
- avacopan
- ATC code
- L04
- Marketing authorisation holder
- ChemoCentryx Ltd
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/004487